Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
KRT17 encodes the type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Additionally we are shipping Keratin 17 Kits (34) and Keratin 17 Proteins (11) and many more products for this protein.
Showing 10 out of 277 products:
Human Monoclonal KRT17 Primary Antibody for ICC, IHC (fro) - ABIN335314
Guelstein, Tchypysheva, Ermilova, Litvinova, Troyanovsky, Bannikov: Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumors, dysplasias and breast cancer. in International journal of cancer. Journal international du cancer 1988
Show all 11 references for 335314
Human Monoclonal KRT17 Primary Antibody for FACS, IHC (fro) - ABIN114619
Litvinov, van Driel, van Rhijn, Bakker, van Krieken, Fleuren, Warnaar: Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation. in The American journal of pathology 1997
Show all 8 references for 114619
Human Monoclonal KRT17 Primary Antibody for IHC, ELISA - ABIN969058
Leigh, Navsaria, Purkis, McKay, Bowden, Riddle: Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. in The British journal of dermatology 1995
Show all 2 references for 969058
Human Polyclonal KRT17 Primary Antibody for IHC (fro), IHC (p) - ABIN126071
Demirkesen, Hoede, Moll: Epithelial markers and differentiation in adnexal neoplasms of the skin: an immunohistochemical study including individual cytokeratins. in Journal of cutaneous pathology 1996
Show all 2 references for 126071
Cow (Bovine) Monoclonal KRT17 Primary Antibody for ELISA, FACS - ABIN4302506
Haisma, Rietveld, de Breij, van Dissel, El Ghalbzouri, Nibbering: Inflammatory and antimicrobial responses to methicillin-resistant Staphylococcus aureus in an in vitro wound infection model. in PLoS ONE 2013
Human Monoclonal KRT17 Primary Antibody for IHC (fro), IHC (p) - ABIN114618
Hachiya, Sriwiriyanont, Fujimura, Ohuchi, Kitahara, Takema, Kitzmiller, Visscher, Tsuboi, Boissy: Mechanistic effects of long-term ultraviolet B irradiation induce epidermal and dermal changes in human skin xenografts. in The American journal of pathology 2009
Human Polyclonal KRT17 Primary Antibody for IHC, IHC (p) - ABIN4302502
Kiflemariam, Andersson, Asplund, Pontén, Sjöblom: Scalable in situ hybridization on tissue arrays for validation of novel cancer and tissue-specific biomarkers. in PLoS ONE 2012
Cow (Bovine) Polyclonal KRT17 Primary Antibody for IHC, WB - ABIN2776962
Rual, Venkatesan, Hao, Hirozane-Kishikawa, Dricot, Li, Berriz, Gibbons, Dreze, Ayivi-Guedehoussou, Klitgord, Simon, Boxem, Milstein, Rosenberg, Goldberg, Zhang, Wong, Franklin, Li, Albala, Lim et al.: Towards a proteome-scale map of the human protein-protein interaction network. ... in Nature 2005
K17 is highly expressed in most cases of both invasive adenocarcinoma and in AIS (show AR Antibodies) and is a powerful, negative prognostic marker for patient survival.
the data suggest that the loss of Krt17 may foster an overall protective environment for lesion-prone cervical tissue.
K17 is expressed in a subset of triple-negative breast cancers, and is a marker of poor prognosis in patients with advanced stage and ER(-)/HER2 (show ERBB2 Antibodies)(-) breast cancer.
MiR (show MLXIP Antibodies)-138 may regulate K17 protein expression to affect cell proliferation and apoptosis by targeting hTERT gene in keratinocytes from psoriatic vulgaris patients.
The pattern of CK17 expression is a highly sensitive marker for distinguishing cutaneous lymphadenoma from basal cell carcinoma in small samples.
Cytokeratin 17 immunoexpression might have a role in evaluating surgical borders in some cases of actinic keratosis and Bowen disease.
These findings suggest that CK17 is involved in the development and metastasis of papillary thyroid carcinoma
Case Report: polycystic kidney disease with steatocystoma multiplex. PKD1 (show PKD1 Antibodies) mutations disrupt keratin 17 polymerization.
our findings establish that K17 functions specially among keratins as an oncoprotein by controlling the ability of p27(KIP1 (show CDKN1B Antibodies)) to influence cervical cancer pathogenesis.
Data indicate that autoimmune regulator Aire mRNA transcripts are regul (show AIRE Antibodies)ated in a keratin 17 (K17) dependent manner in skin tumor keratinocytes.
p53 (show TP53 Antibodies) operates as a direct Krt17 repressor that invites therapeutic targeting in radiodermatitis .
genetic loss of caspase-7 (show CASP7 Antibodies) promotes solar-simulated light-induced skin carcinogenesis by blocking caspase-7 (show CASP7 Antibodies)-mediated cleavage of keratin-17.
Data indicate that keratin 17 (k17) regulates autoimmune regulator Aire (show AIRE Antibodies) to promote skin tumorigenesis.
These findings functionally integrate K17, hnRNP K (show HNRNPK Antibodies), and gene expression along with RSK (show RPS6KA1 Antibodies) and CXCR3 (show CXCR3 Antibodies) signaling in a keratinocyte-autonomous axis and provide a potential basis for their implication in tumorigenesis
KRT17 is necessary for oncogenic transformation in Ewing sarcoma and accounts for much of the GLI1 (show GLI1 Antibodies)-mediated transformation function but via a mechanism independent of AKT (show AKT1 Antibodies) signaling.
Cytochrome b5 (show CYB5A Antibodies) and cytokeratin 17 are biomarkers in bronchoalveolar fluid signifying onset of acute lung injury.
IL-22 (show IL22 Antibodies) up-regulates K17 expression in keratinocytes in a dose-dependent manner through STAT3 (show STAT3 Antibodies)- and ERK1/2 (show MAPK1/3 Antibodies)-dependent mechanisms.
Type I keratin (show KRT12 Antibodies) 17 protein is phosphorylated on serine 44 by p90 (show GPAM Antibodies) ribosomal protein S6 kinase 1 (RSK1 (show RPS6KA1 Antibodies)) in a growth- and stress-dependent fashion
Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin.
This gene encodes the type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Mutations in this gene lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex.
, keratin 17 epitope S1
, keratin 17 epitope S2
, keratin 17 epitope S4
, keratin, type I cytoskeletal 17
, type I keratin KA17
, keratin complex 1, acidic, gene 17
, keratin 17
, keratin 16
, Keratin, type I cytoskeletal 17